Comparison of Efficacy and Safety of a Bevacizumab Biosimilar, in Combination with Chemotherapies, in Nonresectable Metastatic Colorectal Cancer and in Advanced Nonsquamous Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study

• Shalu Kasliwal,
• Ranjith K.,
• Pramod Reddy,
• Narendra Maharaj,
• Gopichand M.,
• Aditya Adhav,
• Kamlesh Harsh,
• Nagesh Madnoorkar,
• Ashok Diwan,
• Mamraj Gupta,
• Ghanshyam Patel,
• Srinivas B. J.,
• Mikhail Vladimirovich Dvorkin

Affiliations

Shalu Kasliwal

Medical Sciences, Dr. Reddy's Laboratories Ltd., Bachupally, Hyderabad, India

Ranjith K.

ORCiD

Clinical Operations, Dr. Reddy's Laboratories Ltd., Bachupally, Hyderabad, India

Pramod Reddy

Biostatistics and Data Management, Dr. Reddy's Laboratories Ltd., Bachupally, Hyderabad, India

Narendra Maharaj

Clinical Development, Dr. Reddy's Laboratories Ltd., Bachupally, Hyderabad, India

Gopichand M.

Department of Oncology, Specialty Surgical Oncology, City Cancer Centre, Vijayawada, India

Aditya Adhav

Department of Oncology, Specialty Surgical Oncology, Curie Manavata Cancer Centre, Nasik, India

Kamlesh Harsh

Department of Oncology, Specialty Radiation Oncology, Acharya Tulsi Regional Cancer Treatment & Research Institute, Bikaner, India

Nagesh Madnoorkar

Department of Oncology, Specialty Surgical Oncology, Manas Hospital, Nasik, India

Ashok Diwan

Department of Radiation Oncology, Government Medical College & Hospital, Nagpur, India

Mamraj Gupta

Department of Oncology, Specialty Surgical Oncology, Asian Cancer Research Institute, Jaipur, India

Ghanshyam Patel

Department of Surgical Oncology, Apple Hospital, Surat, India

Srinivas B. J.

Department of Medical Oncology, Healthcare Global Enterprises Ltd., Bangalore, India

Mikhail Vladimirovich Dvorkin

Department of Oncology, Budgetary Healthcare Institution of Omsk Region “Clinical Oncology Center”, Omsk, Russia